Top Pharmaceuticals companies in Sweden by Debt to Equity Ratio

This ranking features the top 64 Pharmaceuticals companies in Sweden ranked by Debt to Equity Ratio, averaging a Debt to Equity Ratio of 0.91, for January 15, 2025.

Sweden

Pharmaceuticals

#	Name	Debt to Equity Ratio	Reported Date	Stock Price	Change	Country
1	LifeClean International AB (publ) 1 LCLEAN.ST	36.38	Dec. 31, 2023	USD 0.18	4.90%	Sweden
2	Orexo AB (publ) 2 ORX.ST	8.04	Dec. 31, 2023	USD 1.76	2.86%	Sweden
3	ADDvise Group AB (publ) 3 ADDV-B.ST	2.63	Dec. 31, 2023	USD 0.28	0.36%	Sweden
4	Oncopeptides AB (publ) 4 ONCO.ST	2.22	Dec. 31, 2023	USD 0.12	-10.06%	Sweden
5	Medicover AB (publ) 5 MCOV-B.ST	2.02	Dec. 31, 2023	USD 17.18	2.59%	Sweden
6	AddLife AB (publ) 6 ALIF-B.ST	1.07	Dec. 31, 2023	USD 12.08	1.50%	Sweden
7	Essity AB (publ) 7 ESSITY-B.ST	0.86	Dec. 31, 2023	USD 26.00	1.16%	Sweden
8	Arjo AB (publ) 8 ARJO-B.ST	0.72	Dec. 31, 2023	USD 3.30	3.88%	Sweden
9	RaySearch Laboratories AB (publ) 9 RAY-B.ST	0.72	Dec. 31, 2023	USD 20.58	0.68%	Sweden
10	Elekta AB (publ) 10 EKTA-B.ST	0.67	April 30, 2024	USD 5.39	-0.39%	Sweden
11	Bactiguard Holding AB (publ) 11 BACTI-B.ST	0.66	Dec. 31, 2023	USD 3.19	2.10%	Sweden
12	Lifco AB (publ) 12 LIFCO-B.ST	0.63	Dec. 31, 2023	USD 28.08	0.23%	Sweden
13	Swedish Orphan Biovitrum AB (publ) 13 SOBI.ST	0.60	Dec. 31, 2023	USD 28.64	0.87%	Sweden
14	Vimian Group AB (publ) 14 VIMIAN.ST	0.60	Dec. 31, 2023	USD 3.41	3.24%	Sweden
15	Teqnion AB (publ) 15 TEQ.ST	0.49	Dec. 31, 2023	USD 14.61	2.17%	Sweden
16	Prostatype Genomics AB (publ) 16 PROGEN.ST	0.47	Dec. 31, 2023	USD 0.80	0.68%	Sweden
17	Genovis AB (publ.) 17 GENO.ST	0.42	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
18	Magle Chemoswed Holding AB (publ) 18 MAGLE.ST	0.38	Dec. 31, 2023	USD 3.31	2.33%	Sweden
19	Nolato AB (publ) 19 NOLA-B.ST	0.36	Dec. 31, 2023	USD 4.73	3.81%	Sweden
20	Boule Diagnostics AB (publ) 20 BOUL.ST	0.35	Dec. 31, 2023	USD 0.89	14.73%	Sweden
21	Ortivus AB (publ) 21 ORTI-B.ST	0.32	Dec. 31, 2023	USD 0.15	3.82%	Sweden
22	Getinge AB (publ) 22 GETI-B.ST	0.27	Dec. 31, 2023	USD 16.63	0.49%	Sweden
23	Sleep Cycle AB (publ) 23 SLEEP.ST	0.26	Dec. 31, 2023	USD 3.33	0.41%	Sweden
24	MedCap AB (publ) 24 MCAP.ST	0.26	Dec. 31, 2023	USD 52.21	-0.68%	Sweden
25	New Nordic Healthbrands AB (publ) 25 NNH.ST	0.25	Dec. 31, 2023	USD 1.35	-1.92%	Sweden
26	Enzymatica AB (publ) 26 ENZY.ST	0.24	Dec. 31, 2023	USD 0.15	-2.28%	Sweden
27	Swedencare AB (publ) 27 SECARE.ST	0.23	Dec. 31, 2023	USD 3.87	2.52%	Sweden
28	Egetis Therapeutics AB (publ) 28 EGTX.ST	0.21	Dec. 31, 2023	USD 0.52	0.51%	Sweden
29	Intellego Technologies AB 29 INT.ST	0.20	Dec. 31, 2023	USD 2.97	0.98%	Sweden
30	Devyser Diagnostics AB (publ) 30 DVYSR.ST	0.19	Dec. 31, 2023	USD 10.16	-0.20%	Sweden
31	Vitrolife AB (publ) 31 VITR.ST	0.16	Dec. 31, 2023	USD 18.25	2.79%	Sweden
32	Stille AB 32 STIL.ST	0.10	Dec. 31, 2023	USD 19.07	4.08%	Sweden
33	Diamyd Medical AB (publ) 33 DMYD-B.ST	0.09	Aug. 31, 2023	USD 1.61	0.34%	Sweden
34	CellaVision AB (publ) 34 CEVI.ST	0.09	Dec. 31, 2023	USD 18.76	3.89%	Sweden
35	Biovica International AB (publ) 35 BIOVIC-B.ST	0.08	April 30, 2024	USD 0.16	-0.98%	Sweden
36	Arcoma AB 36 ARCOMA.ST	0.08	Dec. 31, 2023	USD 0.97	-2.02%	Sweden
37	Biotage AB (publ) 37 BIOT.ST	0.07	Dec. 31, 2023	USD 11.98	-2.51%	Sweden
38	Iconovo AB (publ) 38 ICO.ST	0.07	Dec. 31, 2023	USD 0.41	1.78%	Sweden
39	Mentice AB (publ) 39 MNTC.ST	0.06	Dec. 31, 2023	USD 2.19	0.18%	Sweden
40	Xspray Pharma AB (publ) 40 XSPRAY.ST	0.05	Dec. 31, 2023	USD 2.83	5.31%	Sweden
41	SpectraCure AB (publ) 41 SPEC.ST	0.05	Dec. 31, 2023	USD 0.27	-5.32%	Sweden
42	Integrum AB (publ) 42 INTEG-B.ST	0.04	April 30, 2024	USD 1.60	-0.43%	Sweden
43	Nanexa AB (publ) 43 NANEXA.ST	0.04	Dec. 31, 2023	USD 0.20	2.06%	Sweden
44	Probi AB (publ) 44 PROB.ST	0.04	Dec. 31, 2023	USD 31.10	0.68%	Sweden
45	Serstech AB 45 SERT.ST	0.04	Dec. 31, 2023	USD 0.12	3.82%	Sweden
46	Mendus AB (publ) 46 IMMU.ST	0.03	Dec. 31, 2023	USD 0.71	-2.02%	Sweden
47	Bonesupport Holding AB (publ) 47 BONEX.ST	0.03	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
48	Senzime AB (publ) 48 SEZI.ST	0.03	Dec. 31, 2023	USD 0.56	4.18%	Sweden
49	SenzaGen AB 49 SENZA.ST	0.02	Dec. 31, 2023	USD 0.61	0.68%	Sweden
50	Sectra AB (publ) 50 SECT-B.ST	0.02	April 30, 2024	USD 22.17	-0.20%	Sweden

1 2

Frequently Asked Questions

Which Pharmaceuticals company in Sweden has the highest Debt to Equity Ratio ?

The Pharmaceuticals company in Sweden with the highest Debt to Equity Ratio is LifeClean International AB (publ) (Stockholm Stock Exchange: LCLEAN.ST) at 36.38.
Which Pharmaceuticals company in Sweden has the lowest Debt to Equity Ratio ?

The Pharmaceuticals company in Sweden with the lowest Debt to Equity Ratio is Hansa Biopharma AB (publ) (Stockholm Stock Exchange: HNSA.ST) at -5.16.

What are the top 10 Pharmaceuticals companies in Sweden by Debt to Equity Ratio ?

The top 10 Pharmaceuticals companies in Sweden by Debt to Equity Ratio are LifeClean International AB (publ), Orexo AB (publ), ADDvise Group AB (publ), Oncopeptides AB (publ), Medicover AB (publ), AddLife AB (publ), Essity AB (publ), Arjo AB (publ), RaySearch Laboratories AB (publ) and Elekta AB (publ).
What are the bottom 10 Pharmaceuticals companies in Sweden by Debt to Equity Ratio ?

The bottom 10 Pharmaceuticals companies in Sweden by Debt to Equity Ratio are Hansa Biopharma AB (publ), Nanologica AB (publ), Linc AB, SynAct Pharma AB, BioGaia AB (publ), Sedana Medical AB (publ), BioArctic AB (publ), C-Rad AB (publ), Moberg Pharma AB (publ) and Clinical Laserthermia Systems AB (publ).